Saving a million puppies from parvo aim of new multi-year campaignJanuary 15, 2024Elanco has launched the “Defend Puppies. Defeat Parvo.” at VMX 2024, encouraging veterinary professionals to ramp up client education about the deadly disease
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Single-dose parvo treatment gets USDA approvalMay 3, 2023Elanco’s Canine Parvovirus Monoclonal Antibody treatment may provide a less intensive solution by targeting the virus with single-dose efficacy in dogs.
Parvo kills dozens of pups in MichiganAugust 25, 2022As many as 60 unvaccinated dogs in northern Michigan have died of parvovirus in recent weeks, the Michigan Department of Agriculture and Rural Development (MDARD) reports.
Canine parvovirus and care (even on a budget)November 17, 2021Puppies infected with canine parvovirus are a common presentation to veterinary practitioners.
Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Preventative for deadly puppy disease may be imminentSeptember 18, 2020An efficacy study of a monoclonal antibody targeting canine parvovirus has shown complete efficacy in its prevention, its maker says.
Canine parvovirus treatment may be in the worksAugust 19, 2019Veterinarians may soon have access to an antibody effective in the treatment of canine parvovirus (CPV).
